Desq Long
Sign in

Cluster

OTLK-2026-08-12-b56d40d2e39e

SEC FORM 4CLUSTER · 3 INSIDERS
$2,499,999.48

Outlook Therapeutics, Inc. (OTLK)

Purchase of 2,777,777 shares across 3 reporting persons.

Transaction Code P · Reporting Persons 3

  • Sukhtian Ghiath M.Purchase of 2,525,252 shares at $0.99 per share.$2,499,999.48
  • Jahr Robert Charles, Chief Executive OfficerPurchase of 151,515 shares; price not stated (see filing).—
  • KENYON LAWRENCE A, Chief Financial OfficerPurchase of 101,010 shares; price not stated (see filing).—

Surfaced by rule: 3 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000899140-26-000894 · filed 2026-08-14 · View filing →

Source: SEC Form 4 · 0001104659-26-097406 · filed 2026-08-14 · View filing →

Source: SEC Form 4 · 0001649989-26-000009 · filed 2026-08-14 · View filing →

Permalink →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Outlook Therapeutics, Inc. (OTLK)." Disclosed 2026-08-14. https://desqlong.com/cards/cluster-OTLK-2026-08-12-b56d40d2e39e (retrieved 2026-09-26).